Drug companies fight medical marijuana | Arkansas Blog

Sunday, September 25, 2016

Drug companies fight medical marijuana

Posted By on Sun, Sep 25, 2016 at 9:02 AM

click to enlarge PROFITABLE: Opioids make big money for drug companies. It prompts them to fight legal marijuana for medicinal use.
  • PROFITABLE: Opioids make big money for drug companies. It prompts them to fight legal marijuana for medicinal use.
Disclosure about financing of the anti-medical marijuana campaign in Arkansas is so far lacking, but it's no secret what's happened in other states — pharmaceutical companies have worked to defeat medical marijuana laws because they create (safer) competition.

For example, here's one article, which notes that lobbying by Big Pharma has long been evident, but says now the efforts have become more direct:

Recently, we saw the first direct evidence that pharmaceutical companies are now working to defeat marijuana legalization efforts, acknowledging that their intent is to protect their market in synthetic opioid drugs.

Earlier this month, Insys Therapeutics Inc., an Arizona-based company, donated $500,000 to a group calling itself Arizonans for Responsible Drug Policy, a newly formed organization established to try to defeat Proposition 205, the marijuana legalization voter initiative that will appear on the ballot this November in that state.

Insys currently markets just one product, Subsys, a sublingual fentanyl spray, a synthetic opioid far more potent than heroin (fentanyl is the drug found in Prince's system following his death in April). "Insys Therapeutics made $62 million in net revenue on Subsys fentanyl sales in the first quarter of this year, representing 100 percent of the company's earnings," according to The Washington Post. "The CDC has implicated the drug in a 'surge' of overdose deaths in several states in recent years."

Survey data compiled from medical marijuana patients show that subjects often reduce their use of prescription drug therapies — particularly opioids — when they have legal access to cannabis. According to a 2015 RAND Corp. study, opiate-related abuse and mortality is lower in jurisdictions that permit medical cannabis access, compared to those that outlaw the plant.


....

When the company first made its half-million dollar contribution to the group opposing the Arizona legalization initiative — the largest single contribution to the group by a factor of four — the company claimed that its reason for opposing the voter initiative was "because it fails to protect the safety of Arizona's citizens and particularly its children."

But when the company filed a legally required disclosure statement with the Securities and Exchange Commission, it acknowledged to shareholders that it was making the donation because it feared a decline in the sales of its powerful opioid product and that of a second drug it is developing: Dranabinol, a synthetic cannabinoid. Synthetic cannibinoid is a blanket term for an artificial version of tetrahydrocannabinol, or THC — the active compound in the marijuana plant — intended to alleviate chemotherapy-caused nausea and vomiting. The company concedes that the scientific literature has confirmed the benefits of natural marijuana over synthetic THC

"Legalization of marijuana or non-synthetic cannabinoids in the United States could significantly limit the commercial success of any dronabinol product candidate. ... If marijuana or non-synthetic cannabinoids were legalized in the United States, the market for dronabinol product sales would likely be significantly reduced, and our ability to generate revenue and our business prospects would be materially adversely affected."

Arkansas
is a leader in disproportionate use of opioids, a fertile ground for drug companies, in other words. Are they putting money into the campaign led by the Arkansas Farm Bureau and the Arkansas State Chamber of Commerce to prevent medical use of marijuana in Arkansas. We may never know. These organizations likely have big enough budgets that their contributions  to the anti-medical marijuana effort won't trigger the reporting law that, for example, required the nursing home lobby to reveal individual contributions by nursing homes to the campaign to pass the amendment to make it just about impossible to sue nursing homes for abuse and neglect.

Already the anti-campaign has dragged out the argument that existing legal drugs are available that provide the active ingredient in marijuana with equivalent efficacy, something even a drug company acknowledges is not true.

From the ArkTimes store

Favorite

Comments (7)

Showing 1-7 of 7

Add a comment

 
Subscribe to this thread:
Showing 1-7 of 7

Add a comment

More by Max Brantley

Readers also liked…

  • The long and winding road: No exception yet for 30 Crossing

    The Arkansas highway department's representative on the Metroplan board of directors told the board today that the department is requesting an exception to the planning agency's cap on six lanes for its 30 Crossing project to widen Interstate 30 from six to 10 (and more) lanes.
    • Jun 29, 2016
  • Baseball fans have a new place to stay

    If you missed out on Razorback baseball home games this year because you couldn’t find a great place to stay, your problem is now solved: Staybridge Suites of Fayetteville is now fully renovated and located directly across from Baum Stadium, with free parking for hotel guests.
    • May 22, 2017
  • Deputy killed, police chief wounded in Sebastian County. Suspect in custody

    40/29 TV reports that two law officers were shot about 7 a.m. today near Hackett in Sebastian County and at mid-afternoon came word that one of them had died. Later in the day a suspect was taken into custody in the shooting.
    • Aug 10, 2016

Most Shared

  • In the margins

    A rediscovered violin concerto brings an oft-forgotten composer into the limelight.
  • Donald Trump is historically unpopular — and not necessarily where you think

    My colleagues John Ray and Jesse Bacon and I estimate, in the first analysis of its kind for the 2018 election season, that the president's waning popularity isn't limited to coastal cities and states. The erosion of his electoral coalition has spread to The Natural State, extending far beyond the college towns and urban centers that voted for Hillary Clinton in 2016. From El Dorado to Sherwood, Fayetteville to Hot Springs, the president's approval rating is waning.
  • Arkansans join House vote to gut Americans with Disabilities Act

    Despite fierce protests from disabled people, the U.S. House voted today, mostly on party lines, to make it harder to sue businesses for violating the Americans with Disabilities Act. Of course Arkansas congressmen were on the wrong side.

Most Viewed

  • The kids are marching open line

    The open line. Kids marching for gun control. And a recollection of how hard it is in Arkansas to restrict gun ownership, even by proven thugs.
  • Another Trump propagandist from Arkansas gets blasted

    If Sarah Huckabee Sanders is Donald Trump's Baghdad Barbie, spouting implausible statements in support of her boss in the style of Saddam's Baghdad Bob, then let's make El Dorado native Hogan Gidley Baghdad Ken.

Most Recent Comments

 

© 2018 Arkansas Times | 201 East Markham, Suite 200, Little Rock, AR 72201
Powered by Foundation